Palo Alto Investors LP 13F Holdings
CIK 0001306923 · PALO ALTO, CA
As of Sep 30, 2025, Palo Alto Investors LP reported 44 positions worth $540.4M in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| INSMED INC | INSM | Healthcare | 491,805 | $70.8M | 13.11% |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 862,613 | $52.9M | 9.80% |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 2,466,684 | $52.6M | 9.74% |
| AMICUS THERAPEUTICS INC | FOLD | Healthcare | 5,367,798 | $42.3M | 7.83% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 754,007 | $40.8M | 7.56% |
| BIOGEN INC | BIIB | Healthcare | 185,661 | $26.0M | 4.81% |
| UNITED THERAPEUTICS CORP | UTHR | Healthcare | 58,186 | $24.4M | 4.51% |
| ANAPTYSBIO INC | ANAB | Healthcare | 673,520 | $20.6M | 3.82% |
| IOVANCE BIOTHERAPEUTICS INC | IOVA | Healthcare | 7,618,132 |